Retrospective prostate cancer diagnostic imaging. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Prostate Cell Line, Tumor Tumor Cells, Cultured Epithelial Cells Neoplastic Stem Cells Chromosomes, Human, Pair 8 Seminal Vesicles Rectum Neoplastic Cells, Circulating Stromal Cells

Organisms4

Mice, Nude Mice, SCID Mice, Transgenic Mice, Inbred BALB C

Diseases35

Neoplasms Prostatic Neoplasms Prostatic Hyperplasia Neoplasms, Hormone-Dependent Disease Progression Adenocarcinoma Neoplasm Metastasis Prostatic Intraepithelial Neoplasia Bone Neoplasms Neoplasm Invasiveness Genetic Predisposition to Disease Breast Neoplasms Lung Neoplasms Neoplasm Recurrence, Local Carcinoma Ovarian Neoplasms Prostatic Neoplasms, Castration-Resistant Colonic Neoplasms Stomach Neoplasms Pancreatic Neoplasms Prostatic Diseases Cell Transformation, Neoplastic Prostatitis Colorectal Neoplasms Urinary Bladder Neoplasms Neovascularization, Pathologic Uterine Cervical Neoplasms Carcinoma, Squamous Cell Disease Models, Animal Carcinoma, Non-Small-Cell Lung Neoplastic Cells, Circulating Rectal Neoplasms Recurrence Radiation Injuries Liver Neoplasms

Chemicals and Drugs64

Prostate-Specific Antigen Receptors, Androgen Androgens Androgen Antagonists Tumor Markers, Biological Tosyl Compounds Antineoplastic Agents Antineoplastic Agents, Hormonal Neoplasm Proteins Androgen Receptor Antagonists Anilides RNA, Messenger Dihydrotestosterone Finasteride Metribolone RNA, Small Interfering Flutamide Anticarcinogenic Agents Taxoids Cancer Vaccines Glutamate Carboxypeptidase II DNA, Neoplasm 5-alpha Reductase Inhibitors PTEN Phosphohydrolase Antigens, Neoplasm Testosterone Congeners Antineoplastic Agents, Phytogenic Testosterone Androstenols Azasteroids 3-Oxo-5-alpha-Steroid 4-Dehydrogenase Nitriles Phenylthiohydantoin Proto-Oncogene Proteins c-akt RNA, Neoplasm Racemases and Epimerases Tumor Suppressor Protein p53 MicroRNAs Transcription Factors Receptor, erbB-2 Leuprolide Cholestenone 5 alpha-Reductase Tumor Suppressor Proteins Antibodies, Monoclonal Estramustine Glutathione S-Transferase pi Receptors, Estrogen Goserelin DNA-Binding Proteins DNA Primers Biological Markers Radiopharmaceuticals Proto-Oncogene Proteins Paclitaxel Enzyme Inhibitors Oncogene Proteins, Fusion Proto-Oncogene Proteins c-bcl-2 Kallikreins Prostatic Secretory Proteins Androgen-Binding Protein Steroid 17-alpha-Hydroxylase Ki-67 Antigen Reagent Kits, Diagnostic Insulin-Like Growth Factor Binding Protein 3

Analytical, Diagnostic and Therapeutic Techniques and Equipment88

Retrospective Studies Prostatectomy Orchiectomy Early Detection of Cancer Sensitivity and Specificity Prognosis Risk Factors Neoplasm Staging Treatment Outcome Neoplasm Grading Follow-Up Studies Reverse Transcriptase Polymerase Chain Reaction Prospective Studies Cohort Studies Case-Control Studies Biopsy Xenograft Model Antitumor Assays Digital Rectal Examination Predictive Value of Tests Risk Assessment Survival Rate Immunohistochemistry Incidence Reproducibility of Results Survival Analysis Neoplasm Transplantation Transplantation, Heterologous Risk Gene Expression Profiling Biopsy, Needle Blotting, Western Transurethral Resection of Prostate Odds Ratio Multivariate Analysis Diagnostic Errors Combined Modality Therapy Polymerase Chain Reaction Logistic Models Disease-Free Survival Diagnostic Imaging ROC Curve Brachytherapy Kaplan-Meier Estimate Registries Oligonucleotide Array Sequence Analysis Tumor Burden Antineoplastic Combined Chemotherapy Protocols Tissue Array Analysis Questionnaires Transfection Diagnostic Tests, Routine Tomography, X-Ray Computed Radiotherapy SEER Program Mass Screening Castration Radiotherapy Dosage Confidence Intervals Nomograms Diagnostic Techniques and Procedures Molecular Targeted Therapy Radiotherapy, Conformal Immunoenzyme Techniques Drug Screening Assays, Antitumor Clinical Trials as Topic Models, Biological Proportional Hazards Models Magnetic Resonance Imaging Flow Cytometry In Situ Hybridization, Fluorescence Gene Knockdown Techniques Disease Models, Animal Enzyme-Linked Immunosorbent Assay Prevalence Chemotherapy, Adjuvant Radiotherapy, Intensity-Modulated Chi-Square Distribution Radiotherapy Planning, Computer-Assisted Positron-Emission Tomography Regression Analysis Real-Time Polymerase Chain Reaction Feasibility Studies Probability Early Diagnosis Statistics, Nonparametric Drug Administration Schedule Reagent Kits, Diagnostic Immunotherapy

Psychiatry and Psychology1

Phenomena and Processes43

Gene Expression Regulation, Neoplastic Sensitivity and Specificity Cell Proliferation Genetic Predisposition to Disease Apoptosis Time Factors Risk Odds Ratio Signal Transduction Genotype Drug Resistance, Neoplasm Cell Growth Processes Down-Regulation Cell Division Cell Survival Cell Movement DNA Methylation Transfection Mutation Up-Regulation Polymorphism, Genetic Promoter Regions, Genetic Dose-Response Relationship, Drug Cell Cycle Nomograms Gene Silencing Gene Fusion Base Sequence Genes, Tumor Suppressor Chromosomes, Human, Pair 8 RNA Interference Gene Expression Polymorphism, Single Nucleotide Phosphorylation Diet Alleles Algorithms Phenotype Transcription, Genetic Genes, Neoplasm Chi-Square Distribution Germ-Line Mutation Probability

Disciplines and Occupations3

Immunohistochemistry Medical Oncology Urology

Anthropology, Education, Sociology and Social Phenomena3

National Cancer Institute (U.S.)Quality of Life Age Distribution

Humanities1

Quality of Life

Information Science12

Survival Rate Incidence Registries Questionnaires SEER Program Radiotherapy, Conformal Base Sequence Molecular Sequence Data Algorithms Prevalence Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted

Named Groups4

European Continental Ancestry Group African Americans Survivors African Continental Ancestry Group

Health Care42

Patient Navigation Retrospective Studies Sensitivity and Specificity Risk Factors Treatment Outcome Follow-Up Studies Prospective Studies Cohort Studies Case-Control Studies Predictive Value of Tests Risk Assessment Survival Rate Watchful Waiting Incidence Reproducibility of Results Survival Analysis Risk Age Factors Odds Ratio Multivariate Analysis Diagnostic Errors Logistic Models Disease-Free Survival ROC Curve Kaplan-Meier Estimate Registries Questionnaires SEER Program Mass Screening National Cancer Institute (U.S.)Confidence Intervals Nomograms Clinical Trials as Topic Proportional Hazards Models Age Distribution Prevalence Chi-Square Distribution Regression Analysis Feasibility Studies Probability Statistics, Nonparametric Radiation Injuries

Geographicals5

United States Sweden Japan China Europe

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Patient Navigation Prostate Neoplasms Prostatic Neoplasms Retrospective Studies Prostate-Specific Antigen Receptors, Androgen Androgens Cell Line, Tumor Androgen Antagonists Prostatectomy Prostatic Hyperplasia Gene Expression Regulation, Neoplastic Orchiectomy Neoplasms, Hormone-Dependent Tumor Markers, Biological Early Detection of Cancer Disease Progression Sensitivity and Specificity Adenocarcinoma Neoplasm Metastasis Mice, Nude Prostatic Intraepithelial Neoplasia Prognosis Risk Factors Neoplasm Staging Bone Neoplasms Tosyl Compounds Neoplasm Invasiveness Treatment Outcome Neoplasm Grading Follow-Up Studies Cell Proliferation Antineoplastic Agents Antineoplastic Agents, Hormonal Genetic Predisposition to Disease Tumor Cells, Cultured Reverse Transcriptase Polymerase Chain Reaction Apoptosis Neoplasm Proteins Prospective Studies Cohort Studies Androgen Receptor Antagonists Breast Neoplasms Case-Control Studies Biopsy Xenograft Model Antitumor Assays Digital Rectal Examination Predictive Value of Tests Risk Assessment Time Factors Survival Rate Immunohistochemistry Anilides Watchful Waiting RNA, Messenger Incidence Reproducibility of Results Survival Analysis Neoplasm Transplantation United States Lung Neoplasms Dihydrotestosterone Neoplasm Recurrence, Local Finasteride Transplantation, Heterologous Risk Carcinoma Gene Expression Profiling Biopsy, Needle Blotting, Western Transurethral Resection of Prostate Ovarian Neoplasms Metribolone Age Factors Odds Ratio Signal Transduction Genotype Drug Resistance, Neoplasm Cell Growth Processes Multivariate Analysis Prostatic Neoplasms, Castration-Resistant Diagnostic Errors RNA, Small Interfering Flutamide Anticarcinogenic Agents Down-Regulation Combined Modality Therapy Colonic Neoplasms Taxoids Polymerase Chain Reaction Cancer Vaccines Glutamate Carboxypeptidase II Logistic Models Disease-Free Survival Cell Division Cell Survival DNA, Neoplasm Diagnostic Imaging ROC Curve

No FAQ available that match "retrospective prostate cancer diagnostic imaging"